Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380201658> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4380201658 endingPage "S258" @default.
- W4380201658 startingPage "S258" @default.
- W4380201658 abstract "Opioids play a significant role in the effective management of cancer-related pain. The COVID-19 lock down may have reduced access to opioids and caused a decline in the use of prescription of opioids among cancer survivors. This study compared opioid prescription rates among cancer survivors before and after the onset of COVID-19 pandemic using real-world electronic health records (EHR). Cohort analyses of cancer patients using data from EHR database from the TriNetX, a global federated health research network across 76 healthcare organizations. We analyzed changes in prescription opioid use before (March 1, 2018, through March 1, 2019) and after onset of COVID-19 (April 01, 2020, through March 2021) among cancer survivors. The key outcome variable was any opioid prescription within 1 year of cancer diagnosis. One-to-one propensity score matching was used to balance the characteristics (age, sex, race, diagnoses including diabetes, hypertensive diseases, overweight, mood disorders, and visual disturbances) of the two cohorts. Data were analyzed using the TriNetX platform. There were 1,502,143 cancer survivors before COVID-19 and 1,412,599 cancer survivors after the onset of COVID-19. The one-to-one propensity-score match yielded 1,382,561 cancer patients, mean age 64 at cancer diagnosis, and 73% were white. Percentage of opioid use among cancer patients declined from 35.6% before the COVID-19 to 35.1% after the onset of the pandemic (OR=0.976, 95% CI 0.971-0.981). Average number of opioid prescriptions within 1 year of cancer diagnosis declined from 5.7 before to 5.3 after the COVID-19 onset (p<0.001). Among cancer survivors, a small decline in prescription opioid use was observed after the onset of COVID-19 pandemic. Future studies are needed to distinguish the impact of revised guidelines, opioid prescription policy changes, and COVID-19 lock down on lower rates of prescription opioid use among cancer survivors." @default.
- W4380201658 created "2023-06-11" @default.
- W4380201658 creator A5039514111 @default.
- W4380201658 creator A5043922488 @default.
- W4380201658 creator A5070068149 @default.
- W4380201658 creator A5072503999 @default.
- W4380201658 date "2023-06-01" @default.
- W4380201658 modified "2023-10-16" @default.
- W4380201658 title "HSD111 Prescription Opioid Use Among Cancer Patients before and after the Onset of COVID-19: Evidence from Real-World Data" @default.
- W4380201658 doi "https://doi.org/10.1016/j.jval.2023.03.2644" @default.
- W4380201658 hasPublicationYear "2023" @default.
- W4380201658 type Work @default.
- W4380201658 citedByCount "0" @default.
- W4380201658 crossrefType "journal-article" @default.
- W4380201658 hasAuthorship W4380201658A5039514111 @default.
- W4380201658 hasAuthorship W4380201658A5043922488 @default.
- W4380201658 hasAuthorship W4380201658A5070068149 @default.
- W4380201658 hasAuthorship W4380201658A5072503999 @default.
- W4380201658 hasBestOaLocation W43802016581 @default.
- W4380201658 hasConcept C121608353 @default.
- W4380201658 hasConcept C126322002 @default.
- W4380201658 hasConcept C170493617 @default.
- W4380201658 hasConcept C17923572 @default.
- W4380201658 hasConcept C2426938 @default.
- W4380201658 hasConcept C2779159551 @default.
- W4380201658 hasConcept C2781063702 @default.
- W4380201658 hasConcept C71924100 @default.
- W4380201658 hasConcept C98274493 @default.
- W4380201658 hasConceptScore W4380201658C121608353 @default.
- W4380201658 hasConceptScore W4380201658C126322002 @default.
- W4380201658 hasConceptScore W4380201658C170493617 @default.
- W4380201658 hasConceptScore W4380201658C17923572 @default.
- W4380201658 hasConceptScore W4380201658C2426938 @default.
- W4380201658 hasConceptScore W4380201658C2779159551 @default.
- W4380201658 hasConceptScore W4380201658C2781063702 @default.
- W4380201658 hasConceptScore W4380201658C71924100 @default.
- W4380201658 hasConceptScore W4380201658C98274493 @default.
- W4380201658 hasIssue "6" @default.
- W4380201658 hasLocation W43802016581 @default.
- W4380201658 hasLocation W43802016582 @default.
- W4380201658 hasOpenAccess W4380201658 @default.
- W4380201658 hasPrimaryLocation W43802016581 @default.
- W4380201658 hasRelatedWork W2183638947 @default.
- W4380201658 hasRelatedWork W2335037405 @default.
- W4380201658 hasRelatedWork W2522181602 @default.
- W4380201658 hasRelatedWork W2531622177 @default.
- W4380201658 hasRelatedWork W2982701920 @default.
- W4380201658 hasRelatedWork W3026984660 @default.
- W4380201658 hasRelatedWork W3174783347 @default.
- W4380201658 hasRelatedWork W4200481586 @default.
- W4380201658 hasRelatedWork W4200501282 @default.
- W4380201658 hasRelatedWork W4285241235 @default.
- W4380201658 hasVolume "26" @default.
- W4380201658 isParatext "false" @default.
- W4380201658 isRetracted "false" @default.
- W4380201658 workType "article" @default.